Evidence map›Paper›PMID 36466825›Full record

ArticleFrontiers in immunology2022

Photodynamic therapy improves the clinical efficacy of advanced colorectal cancer and recruits immune cells into the tumor immune microenvironment.

Baohong Gu, Bofang Wang, Xuemei Li, Zedong Feng, Chenhui Ma, Lei Gao, Yang Yu, Jing Zhang, Peng Zheng, Yunpeng Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Baohong GuSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Bofang WangSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Xuemei LiSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Zedong FengSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Chenhui MaSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Lei GaoSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Yang YuSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Jing ZhangSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Peng ZhengSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Yunpeng WangSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Haiyuan LiSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Tao ZhangSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Hao ChenSecond Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Lanzhou University · CNLanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Although photodynamic therapy (PDT) has been proven effective in various tumors, it has not been widely used as a routine treatment for colorectal cancer (CRC), and the characteristics of changes in the tumor microenvironment (TME) after PDT have not been fully elucidated. This study evaluated the efficacy of PDT in patients with advanced CRC and the changes in systemic and local immune function after PDT. Methods: Patients with stage III-IV CRC diagnosed in our hospital from November 2020 to July 2021 were retrospectively analyzed to compare the survival outcomes among each group. Subsequently, short-term efficacy, systemic and local immune function changes, and adverse reactions were assessed in CRC patients treated with PDT. Results: A total of 52 CRC patients were enrolled in this retrospective study from November 2020 to July 2021, and the follow-up period ended in March 2022. The overall survival (OS) of the PDT group was significantly longer than that of the non-PDT group ( Conclusion: PDT is effective for CRC without significant side effects according to the available data. It alters the TME by recruiting immune cells into tumor tissues.

Indexed as

Colorectal NeoplasmsPhotochemotherapyCD8-Positive T-LymphocytesHumansLeukocyte CountRetrospective StudiesTreatment OutcomeTumor Microenvironmentclinical efficacycolorectal cancerimmunityphotodynamic therapy (PDT)tumor microenvironment

Identifiers

PMID36466825
PMCPMC9716470
OpenAlexW4309464199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.